logo

CLOV: Riding the Market Waves of Growth and Decline in 2023

PNC Stock

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -22.59%.However, over the last six months, we can see a stronger performance of -31.76%. Over the last 30 days, the price of CLOV has leaped by -14.82%. And in the last five days, it has fallen by -6.83%.

Clover Health Investments Corp experienced a rather shaky stock market performance. The highest value in the past year was recorded at $1.63 on 08/09/23 and the lowest value was $0.71 on 04/26/23.

52-week price history of CLOV Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Clover Health Investments Corp’s current trading price is -54.79% away from its 52-week high, while its distance from the 52-week low is 4.13%. The stock’s price range during this period has varied between$0.71 and $1.63. The Clover Health Investments Corp’s shares, which operate in the Healthcare, saw a trading volume of around 6.83 million for the day, a figure considerably lower than their average daily volume of 9.5 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Clover Health Investments Corp (CLOV) has experienced a quarterly decline of -22.59% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 363.72M and boasts a workforce of 552 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.9278, with a change in price of -0.3930. Similarly, Clover Health Investments Corp recorded 9,053,171 in trading volume during the last 100 days, posting a change of -34.78%.

CLOV’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CLOV stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.

CLOV Stock Stochastic Average

Clover Health Investments Corp’s raw stochastic average for the past 50 days is presently 4.84%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 8.18%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 24.07% and 32.18%, respectively.